欢迎来到 Biomatik中国区代理商/公司/官网
全国咨询热线: 18771997407
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:13212737804

传真:18771997407

邮箱:sales@amyjet.com

新闻中心
2.5比1.pngexocell.jpg

艾美捷科技代理Sequins品牌。

sequins.bio 是一家解决基因组学领域核心痛点——数据质量、可靠性和标准化——的创新公司。他们开发的合成 DNA 标准品 “sequins” 作为一种“分子尺子”和“内部间谍”,被整合到样本中一起进行测序分析,为整个流程提供了前所未有的透明度和可溯源性。这使得实验室能够:监控实验过程偏差;评估技术和流程性能;验证生物信息分析结果的准确性;标准化不同来源的数据。

         IMG_20250626_142550.jpg   IMG_20250626_141842(1).png       IMG_20250626_142621.jpg       

尤其在精准医疗和临床诊断领域,sequins.bio 的技术对于确保基因检测结果的可靠性和可比性,从而支持准确的临床决策至关重要。他们代表了基因组学质量控制从简单的“输入/输出”检查向基于已知真相的、全流程、分析性能导向的质控演进的重要方向。


核心业务包括:

● 全基因组测序(WGS)已成为识别致病性遗传变异的有力工具。

● 宏基因组学(Metagenomics)能够实现对病原体检测和抗微生物药物耐药性筛查的精准微生物分析。

● 循环肿瘤DNA(ctDNA)检测Sequins内标标准品为ctDNA检测提供了有力的质控工具。



更多详情请咨询

二维码图片.png

全国免费热线:400-6800-868

直拨专线:+86-027-59626688;18771997407

客服QQ一:17754422825;

客服QQ二:18771149750

公司地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋13

咨询和订购邮箱:sales@amyjet.com 


" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Sequins全系列产品">
艾美捷科技代理Sequins全系列产品
...
阅读详情
ScreenFect-Logo_neu_21_2c08d653e1ee60d55cd0da551026ea56.png

艾美捷科技代理Screenfect品牌全系列产品


ScreenFect GmbH成立于2012年,是一家专注于细胞转染技术创新的德国生物技术公司。ScreenFect®转染试剂是该公司的核心产品,是依托组合化学方法构建独特化学文库,通过高通量细胞筛选平台高效开发的转染试剂。ScreenFect®转染试剂适用于多种核酸分子(包括pDNA、siRNA、mRNA、miRNA)的单转染与共转染,在难转染细胞(如原代细胞、干细胞)中具有优异性能。


Screenfect页面.png


▎ScreenFect®转染试剂

● ScreenFect®A是一款通用型转染试剂,适用于pDNA、siRNA、mRNA的递送以及共转染实验,可广泛应用于多种细胞系(如HEK、HeLa、MEF)及部分原代细胞系。高效转染:在96孔板中仅需低于100ng DNA即可实现高转染效率。

● ScreenFect®siRN 是转染小干扰RNA双链体的理想选择,适用于HEK、HeLa、MEF等标准哺乳动物细胞系及多种原代细胞系。

● ScreenFect®mRNA是专为mRNA转染优化的高效试剂。

● ScreenFect®A-plus是一款多功能增强型转染试剂,适用于pDNA、siRNA、mRNA的转染及共转染实验,在几乎所有细胞系(包括难转染细胞)中均能实现高效转染。


货号品名规格Dilution buffer
S-3001ScreenFect®A1 mL50 mL
S-3001-2ScreenFect®A0,2 mL10 mL
S-4001ScreenFect®siRNA1 mL50 mL
S-4001-2ScreenFect®siRNA0,2 mL10 mL
S-5001ScreenFect®mRNA1 mL50 mL
S-5001-2ScreenFect®mRNA0,2 mL10 mL
S-6001ScreenFect®A-plus1 mL50 mL
S-6001-2ScreenFect®A-plus0,2 mL10 mL
S-2001-2ScreenFect Buffer10 mL-
S-2001ScreenFect Buffer50 mL-


ScreenFect®转染试剂具有以下特点:

● 低细胞毒性:显著降低对细胞活性的影响

● 省时一步法:支持细胞铺板与转染同步操作(即用型方案)

● 快速优化:针对新用户/新细胞系提供简易优化流程

● 血清兼容性:无需更换培养基,可直接在含血清环境下使用

● 无动物源成分:杜绝动物源性物质污染风险

● 高通量适用:完美适配大规模筛选实验需求


ScreenFect®UP-293

ScreenFect®UP-293 是一款专为高效生产抗体及蛋白设计的转染试剂,适用于HEK 293-F悬浮细胞体系。配合ScreenFect®Booster增效剂使用,可最大化提升悬浮细胞中的蛋白产量。


产品编号悬浮培养体积组分组分体积
S-8010-0.5L0.5 litreScreenFect®UP-2931 mL
ScreenFect®Booster2.5 mL
ScreenFect®Buffer35 mL
S-8010-1L1 litreScreenFect®UP-2932 mL
ScreenFect®Booster5 mL
ScreenFect®Buffer70 mL
S-8010-10L10 litresScreenFect®UP-29320 mL
ScreenFect®Booster50 mL
ScreenFect®Buffer700 mL
S-8010-50L50 litresScreenFect®UP-293100 mL
ScreenFect®Booster250 mL
ScreenFect®Buffer3.5 L
<

ScreenFect®Booster

在完成HEK293F悬浮细胞的ScreenFect®UP-293转染后,于转染后16小时添加ScreenFect®Booster增效剂,可显著提升蛋白产量。该增效剂含特定复合组分,通过重编程细胞代谢路径(从增殖模式转向蛋白合成模式),从而高效提升大多数目标蛋白的表达水平。


货号品名规格
S-2001-2ScreenFect Buffer10 mL
S-2001ScreenFect Buffer50 mL


" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Screenfect品牌全系列产品">
艾美捷科技代理Screenfect品牌全系列产品
...
阅读详情
Schircks Laboratories LOGO.jpg


艾美捷科技代理Schircks Laboratories品牌。

瑞士Schircks Laboratories由B.Schircks博士于1980年创立,主要生产蝶啶及蝶啶类化合物(Pteridines)。至今,Schircks实验室合成了100多种蝶啶类化合物,主要用于科学研究和临床诊断应用。产品包括:

<
11.1806-(L-1,2,3-Trihydroxybutyl)-pterin [Rhamnopterin]
11.182(6R,S)-5,6,7,8-Tetrahydro-L-rhamnopterin dihydrochloride
11.203L-Biopterin [L-erythro-Biopterin] 
11.2067,8-Dihydro-L-biopterin
11.209(6R,S)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride 
11.212(6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride
11.213(6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride
11.215(6S)-5,6,7,8-Tetrahydro-L-biopterin sulfate
11.216(6S)-5,6,7,8-Tetrahydro-L-biopterin sulfate
11.217(6R)-5-Methyl-5,6,7,8-tetrahydro-L-biopterin dihydrochloride
11.218D-Biopterin [D-erythro-Biopterin]
11.220(6R,S)-5,6,7,8-Tetrahydro-D-biopterin dihydrochloride
11.221D-threo-Biopterin [Dictyopterin] 
11.223(6R,S)-5,6,7,8-Tetrahydro-D-threo-biopterin dihydrochloride 
11.228Deoxysepiapterin
11.2296-((1R,S)-Hydroxypropyl)pterin [(1'R,S)-2'-Deoxybiopterin]
11.2317-Biopterin 
11.2347-Tetrahydro-L-biopterin dihydrochloride
11.260Oncopterin
11.2704-Hydroxy-6-(L-erythro-1,2-dihydroxy-propyl)-2-(methylthio)pteridine
11.2804-Amino-L-biopterin [2,4-Diamino-6-(L-erythro-1',2'-dihydroxypropyl)pteridine]
11.2824-Amino-(6R,S)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride
11.2834-Amino-(6R)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride
11.303D-Neopterin [D-erythro-Neopterin] 
11.3067,8-Dihydro-D-neopterin  
11.3077,8-Dihydro-D-neopterin-3’-triphosphate  (Please refer to our reference 8)
11.309(6R,S)-5,6,7,8-Tetrahydro-D-neopterin dihydrochloride
11.314D-Neopterin-3’-monophosphate, lithium salt
11.3157,8-Dihydro-D-neopterin-3’-monophosphate, lithium salt  
11.3203'-Hydroxy-D-sepiapterin
11.3307-Neopterin  
11.340L-Monapterin [L-threo-Neopterin]
11.3457,8-Dihydro-L-monapterin
11.346(6R,S)-5,6,7,8-Tetrahydro-L-monapterin dihydrochloride
11.349D-Monapterin [D-threo-Neopterin]
11.403Pterin-6-carboxylic acid
11.409Pterin-7-carboxylic acid
11.4156-Formylpterin [Pterin-6-aldehyde]
11.4166-Formyl-7,8-dihydropterin
11.418Acetyl-6-formylpterin
11.4206-Hydroxymethylpterin
11.4216-Hydroxymethyl-7,8-dihydropterin hydrochloride
11.4226-Hydroxymethyl-7,8-dihydropterin-diphosphate    (Please refer to our reference 8)
11.423(6R,S)-6-Hydroxymethyl-5,6,7,8-tetrahydropterin dihydrochloride
11.4296-Hydroxymethylpterin-monophosphate 
11.4386-Hydroxymethylpterin-diphosphate, lithium salt  
11.4806-Methylpterin
11.4816-Methyl-7,8-dihydropterin hydrochloride
11.483(6R,S)-6-Methyl-5,6,7,8-tetrahydropterin dihydrochloride
11.5036,7-Dimethylpterin
11.5066,7-Dimethyl-7,8-dihydropterin monohydrochloride
11.5096,7-Dimethyl-5,6,7,8-tetrahydropterin monohydrochloride
11.703Leucopterin
11.713Xanthopterin
11.716Dihydroxanthopterin
11.723Isoxanthopterin
11.903Pterin
11.9067,8-Dihydropterin  (Please refer to our reference 20)
11.9095,6,7,8-Tetrahydropterin dihydrochloride
13.103Lumazine
13.2036-Hydroxylumazine
13.2066-Hydroxy-7,8-dihydrolumazine
13.2207-Hydroxylumazine
16.113Pteroic acid
16.123N10-(Trifluoroacetyl)pteroic acid
16.14010-Formylpteroic acid
16.203Folic acid  
16.2067,8-Dihydrofolic acid
16.208(6S)-5,6,7,8-Tetrahydrofolic acid trihydrochloride  
16.209(6R,S)-5,6,7,8-Tetrahydrofolic acid trihydrochloride 
16.21110-Methylfolic acid
16.21510-Formylfolic acid  
16.21710-Formyl-5,6,7,8-tetrahydrofolic acid  (Please refer to our reference 19)
16.220(6R,S)-5-Formyl-5,6,7,8-tetrahydrofolic acid, calcium salt 
16.222(6R)-5-Formyl-5,6,7,8-tetrahydrofolic acid, calcium salt (unnatural calcium folinate)  
16.230(6R,S)-5,10-Methenyl-5,6,7,8-tetrahydrofolic acid chloride
16.233(6R,S)-5-Methyl-5,6-dihydrofolic acid, ammonium salt  
16.235(6R,S)-5-Methyl-5,6,7,8-tetrahydrofolic acid, calcium salt
16.236(6S)-5-Methyl-5,6,7,8-tetrahydrofolic acid, calcium salt
16.243(6R,S)-5-Methyl-5,6,7,8-tetrahydropteroyltri-γ-L-glutamic acid trihydrochloride
16.244(6R,S)-5-Methyl-5,6,7,8-tetrahydropteroyltetra-γ-L-glutamic acid trihydrochloride
16.252Pteroyldi-γ-L-glutamic acid  
16.253Pteroyltri-γ-L-glutamic acid   has been discontinued
16.254Pteroyltetra-γ-L-glutamic acid  
16.255Pteroylpenta-γ-L-glutamic acid  has been discontinued
16.266Pteroylhexa-γ-L-glutamic acid, ammonium salt
16.267Pteroylhepta-γ-L-glutamic acid, ammonium salt  
16.280(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroic acid
16.282(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyldi-γ-L-glutamic acid, lithium salt has been discontinued
16.283(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyltri-γ-L-glutamic acid, lithium salt has been discontinued
16.284(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyltetra-γ-L-glutamic acid, lithium salt
16.285(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroylpenta-γ-L-glutamic acid, lithium salt
16.286(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroylhexa-γ-L-glutamic acid, lithium salt
16.330Aminopterin [4-Aminofolic acid]
16.4034-Amino-10-methylpteroic acid (APA, DAMPA)
16.411Methotrexate  [4-Amino-10-methylpteroyl-γ-L-glutamic acid]
16.4124-Amino-10-methylpteroyldi-γ-L-glutamic acid, ammonium salt [Methotrexate diglutamate]
16.4134-Amino-10-methylpteroyltri-γ-L-glutamic acid, ammonium salt [Methotrexate triglutamate] 
16.4144-Amino-10-methylpteroyltetra-γ-L-glutamic acid, ammonium salt [Methotrexate tetraglutamate] 
16.4154-Amino-10-methylpteroylpenta-γ-L-glutamic acid, ammonium salt [Methotrexate pentaglutamate]
16.4164-Amino-10-methylpteroylhexa-γ-L-glutamic acid, ammonium salt [Methotrexate hexaglutamate]
16.4174-Amino-10-methylpteroylhepta-γ-L-glutamic acid, ammonium salt [Methotrexate heptaglutamate] 
16.5007-Hydroxymethotrexate   
16.701p-Aminobenzoyl-L-glutamic acid
16.702p-Aminobenzoyldi-γ-L-glutamic acid, ammonium salt  
16.703p-Aminobenzoyltri-γ-L-glutamic acid, ammonium salt  
16.704p-Aminobenzoyltetra-γ-L-glutamic acid, ammonium salt  
16.705p-Aminobenzoylpenta-γ-L-glutamic acid, ammonium salt  
16.706p-Aminobenzoylhexa-γ-L-glutamic acid,  ammonium salt 
16.707p-Aminobenzoylhepta-γ-L-glutamic acid, ammonium salt  has been discontinued
16.901Z-Glu-OtBu
16.902Z-Glu2-OtBu3
16.903Z-Glu3-OtBu4  
16.904Z-Glu4-OtBu5  
16.905Z-Glu5-OtBu6  
16.906Z-Glu6-OtBu7  
91.303D-(5-15N)-Neopterin
96.203(5-15N)-Folic acid 
< " data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Schircks Laboratories品牌">
艾美捷科技代理Schircks Laboratories品牌
...
阅读详情
Logotype-SynthelisBiotech (1).png

<

艾美捷科技代理Synthelis Biotech品牌全系列产品


Synthelis Biotech是一家法国公司,专注于蛋白质的生产、纯化与表征,公司致力于助力疫苗、生物制剂、酶、工程蛋白、诊断工具以及高通量分子或配体筛选技术的开发。Synthelis Biotech提供经过验证的蛋白质,其活性和纯度均根据特定应用(候选药物筛选、抗体与疫苗开发、结构生物学、体外诊断、蛋白质载体化)量身定制。Synthelis Biotech专利的无细胞技术使客户能够从不同蛋白家族(GPCRs、离子通道、转运蛋白等)和不同形式(蛋白脂质体、纳米盘、去垢剂溶解形式或可溶形式)中选择合适的蛋白质。凭借其专利技术,Synthelis 能够在数小时内合成各类蛋白质:包括膜蛋白、毒性蛋白、修饰蛋白等,应用于药物筛选、疫苗与抗体开发、结构生物学以及体外诊断等领域。同时可按需进行修饰(荧光或同位素标记、非天然氨基酸掺入、截短或突变形式等)。


SynthelisBiotech页面.png


▍Synthelis Biotech产品列表


分类品名ProteinOriginFormatReferenceQuantity分子量
Viral ProteinsE1Envelop protein 1Hepatitis C virusProteoliposomePL01110µg, 20µg, 50µg, 100µg, 200µg, 500µg21 kDa
Viral ProteinsE2Envelop protein 1Hepatitis C virusProteoliposomePL01010µg, 20µg, 50µg, 100µg, 200µg, 500µg21 kDa
Viral ProteinsN-proteinNucleocapsid Protein (COVID-19)SARS-Cov 2 virusSolubleS-14410µg, 20µg, 50µg, 100µg, 200µg, 500µg47,7 kDa
Viral ProteinsF5LVaccinia virus major membrane proteinVaccinia virusProteoliposomePL00710µg, 20µg, 50µg, 100µg, 200µg, 500µg39.0 kDa
Viral ProteinsHCV p7Hepatitis C virus P7HCV virusProteoliposomePL04210µg, 20µg, 50µg, 100µg, 200µg, 500µg7 kDa
GPCRsAPJ/ARApelin ReceptorHumanProteoliposomePL06110 µg, 50 µg ,100 µg44.7 kDa
GPCRsB2RBradykinin receptor 2HumanProteoliposomePL08010 µg, 50 µg ,100 µg47.0 kDa
GPCRsBRBacteriorhodopsinBacteriaProteoliposomePL02710 µg, 50 µg ,100 µg29.4 kDa
GPCRsCCR1C-C chemokine receptor type 1HumanProteoliposomePL02110 µg, 50 µg ,100 µg43.7 kDa
GPCRsCCR2aC-C chemokine receptor type 2, isoform aHumanProteoliposomePL02210 µg, 50 µg, 100 µg44.5 kDa
GPCRsCCR2bC-C chemokine receptor type 2, isoform bHumanProteoliposomePL02310µg, 20µg,100 µg, 200 µg42 kDa
GPCRsCCR5C-C chemokine receptor type 5HumanProteoliposomePL02410µg, 20µg ,100 µg , 200 µg, 500 µg,bulk40 kDa
GPCRsCXCR4C-X-C chemokine receptor type 4HumanProteoliposomePL01610 µg, 50 µg, 100 µg43 kDa
GPCRsCXCR4-DetergentC-X-C chemokine receptor type 4HumanDetergentD01625µg ,100 µg ,500 µg,bulk40 kDa
GPCRsGLP1RGlucagon-like peptide 1 receptorHumanProteoliposomePL06710 µg, 50 µg, 100 µg55.5 kDa
GPCRsGPR50G-protein coupled receptor 50HumanProteoliposomePL09510 µg, 50 µg, 100 µg67.4 kDa
GPCRsGPR54G-protein coupled receptor 54HumanProteoliposomePL09710 µg, 50 µg ,100 µg45.2 kDa
GPCRsHMOPMu-type opioid receptorHumanProteoliposomePL025--
GPCRsMT1Melatonin receptorHumanProteoliposomePL02810µg, 20µg ,100 µg , 200 µg, 500 µg,bulk40 kDa
GPCRsRXFP1Relaxin receptor 1HumanProteoliposomePL06810 µg, 50 µg ,100 µg89.1 kDa
Ion Channelskir1.1bATP-sensitive inward rectifier potassium channel 1 isoform bMouseProteoliposomePL03110µg, 20µg,100 µg, 200 µg, 500 µg, bulk42.7 kDa
Ion Channelskv1.2Potassium voltage-gated channel subfamily A, member 2RatProteoliposomePL03710µg, 20µg ,100 µg , 200 µg, 500 µg,bulk57 kDa
Ion Channelskv1.3Potassium voltage-gated channel subfamily A, member 3MouseProteoliposomePL03610µg, 20µg ,100 µg , 200 µg, 500 µg,bulk58 kDa
Ion ChannelsVDAC1Voltage-Dependent Anion Channel 1HumanProteoliposomePL02910 µg, 50 µg ,100 µg30.7kDa
Ion ChannelsVDAC1 – DetergentVoltage-Dependent Anion Channel 1HumanDetergentD02910 µg, 50 µg, 100 µg30.7kDa
LigandsSDF1aStromal cell-derived factor 1HumanSolubleS06910 µg, 50 µg ,100 µg10.7 kDa
PorinsOEP24Outer envelope pore protein 24, chloroplasticPlantProteoliposomePL04010 µg, 50 µg ,100 µg24 kDa
PorinsOprFOuter membrane porin FBacteriaProteoliposomePL04510 µg, 50 µg, 100 µg40 kDa
Enzymesgp91phox (Nox2 subunit)gp91phoxHumanProteoliposomePL00810µg, 20µg ,100 µg , 200 µg, 500 µg,bulk55 kDa
EnzymesKMOKynurenine 3-monooxygenaseHumanProteoliposomePL00510µg, 20µg ,100 µg , 200 µg, 500 µg,bulk55,8 kDa
EnzymesNox2, p22 PhoxCytochrome b-245 light chainHumanProteoliposomePL03910 µg, 50 µg ,100 µg23,5 kDa
EnzymesNox4Nox4HumanProteoliposomePL05910µg, 20µg ,100 µg , 200 µg, 500 µg,bulk67 kDa
EnzymesPORCNProtein-Cysteine N-palmitoyltransferase porcupineHumanProteoliposomePL00610 µg, 50 µg, 100 µg55.5 kDa
EnzymesTFTissue factorHumanProteoliposomePL05310µg, 20µg ,50µg, 100 µg , 200µg, 500 µg,bulk33 kDa
EnzymesT7 RNA PolT7 RNA PolymeraseBacteriophage T7SolubleS19210 µg, 50 µg, 100µg100.1 kDa
EnzymesDsbCDisulfide bond isomeraseE.coliSolubleS197customized quantity on request.25.4 kDa
ReceptorsCLDN 18.2Claudin 18.2 ProteinHumanProteoliposomePL11910 µg, 50 µg, 100 µg30 kDa
Transcriptional regulatorsAROSActive regulator of SIRT1HumanProteoliposomeS05210µg, 20µg ,100 µg , 200 µg, 500 µg,bulk15,4 kDa
TransportersBakBcl-2 homologous antagonist killerHumanProteoliposomePL03825µg ,100 µg ,500 µg,bulk17 kDa
TransportersEspHCytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coliBacteriaProteoliposomePL05110 µg, 50 µg, 100 µg21.9 kDa
TransportersHCV p7Hepatitis C virus P7VirusProteoliposomePL04225µg ,100 µg ,500 µg,bulk7 kDa
TransportersNhaANa(+)/H(+) antiporter NhaAE. coliProteoliposomePL03210 µg, 50 µg, 100 µg43.9 kDa
TransportersUCP1Mitochondrial brown fat uncoupling protein 1MitochondriaProteoliposomePL04710 µg, 50 µg, 100 µg35.1 kDa
" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Synthelis Biotech品牌全系列产品">
艾美捷科技代理Synthelis Biotech品牌全系列产品
...
阅读详情
Amid bioscience 2.5比1.png

<

艾美捷科技代理Amid Biosciences品牌全系列产品


Amid Biosciences是一家专注于生命科学研究和相关产品开发与制造的品牌,在蛋白质工程和酶开发、蛋白质表达和纯化等领域具备核心优势,尤其擅长利用细菌(如大肠杆菌、枯草芽孢杆菌)、酵母系统以及克隆试剂,为学术、工业和政府实体提供蛋白质表达工具。Amid Biosciences公司致力于帮助生物医学研究人员节省时间和成本,以实现研究目标,并以具有竞争力的价格提供高质量产品。公司产品线包括:生物素化工具和链霉亲和素、RAS 蛋白、鞘脂激活蛋白、噬菌体展示感受态细胞、感受态大肠杆菌细胞、炎症反应蛋白、磁性纳米颗粒、改性琼脂糖树脂、核酸染料和蛋白质可视化、质粒、聚合酶和PCR、蛋白酶、蛋白质表达载体、重组蛋白、RNA合成与修饰。


AmidBiosciences页面.png


Amid Biosciences产品线

● 生物素化工具和链霉亲和素:提供高质量的重组BirA生物素连接酶、链霉亲和素和链霉亲和素荧光偶联物,以及用于蛋白质表达和体内生物素化的BL21 (λDE3) pBirA菌株。

● RAS蛋白:Amid Biosciences提供广泛的重组生物素化和非生物素化KRAS蛋白,以及参与KRAS调节的关键生物分子,支持药物发现和医学研究。

● 感受态大肠杆菌细胞:用于分子克隆、DNA文库构建、噬菌体展示、重组蛋白表达和诱变的必要工具。Amid Biosciences提供多种用于体内生物素化的菌株,以及高效化学感受态和电感受态大肠杆菌细胞。

● 噬菌体展示感受态细胞:用于高通量文库筛选的噬菌体展示技术,适用于克隆、亚克隆和蛋白质表达。Amid Biosciences提供化学和电化学两种形式的高效噬菌体展示大肠杆菌细胞。

 鞘脂激活蛋白/皂苷:皂苷或鞘脂激活蛋白(SAP)是存在于溶酶体中的小非酶糖蛋白,具有多种应用,包括脂质代谢研究、药物输送系统、癌症治疗等。

 炎症反应蛋白:炎症反应涉及复杂的细胞和介质网络,包括细胞因子和可溶性受体。了解炎症反应途径和分子机制对预防和治疗炎症性疾病非常重要。

 磁性纳米颗粒:用于捕获、分离或纯化细胞、蛋白质、抗体和核酸等靶标。Amid Biosciences提供多种功能化磁性颗粒和配体。

 改性琼脂糖树脂:用于酶和抗体的亲和纯化,Amid Biosciences提供高容量醛琼脂糖珠和链霉亲和素琼脂糖珠。

 核酸染料和蛋白质可视化:提供ZicherGreen和ZicherRed核酸安全凝胶染色剂,作为致突变溴化乙锭的替代品。这些染色剂是高灵敏度且环保的荧光核酸染料,用于检测琼脂糖和聚丙烯酰胺凝胶中的DNA和RNA。

 质粒:提供一系列常见质粒,用于克隆实验和应用,例如蛋白质表达和基因表达。pUC18和pUC19质粒提供了克隆限制性内切酶产生的DNA片段的选项,由于体积小,能够成功克隆大DNA片段。

 蛋白酶:提供重组TEV、HRV 3C、SenP2蛋白酶,用于在蛋白质纯化过程中去除亲和标签和融合伙伴。

 蛋白质表达载体:细菌表达载体允许在大肠杆菌中快速表达和随后大规模、经济高效地生产重组蛋白。拥有许多专有的表达载体,用于有效的高水平重组蛋白表达。

● 重组蛋白:使用专有的表达和纯化技术来生产高纯度的高产量重组蛋白和酶。蛋白质集合包括链霉亲和素、BirA生物素连接酶、Lambda蛋白磷酸酶、HRV 3C蛋白酶、TEV蛋白酶等。

● RNA合成与修饰:提供一系列用于RNA研究的产品,包括用于合成和修饰的试剂。产品包括T7 RNA聚合酶、大肠杆菌聚(A)聚合酶、T4 RNA连接酶1和2、鼠RNA酶抑制剂。


Amid Biosciences部分产品列表


品名规格货号
BL21(λDE3)pBirA Chemically Competent E.coli Cells for in vivo Biotinylation10x0.1 ml (20 reactions)BLB-201
BirA Biotin Protein Ligase, Recombinant100 ugBBL-301
High Capacity Streptavidin Agarose Beads1 mLSA-101-1
BirA Biotin Ligase, MBP-tag, Recombinant0.1 mgMBBL-301
BirA Biotin Ligase, GST-tag0.1 mgBBL-G-301
G12C KRAS(1-166), Biotinylated at the C-terminus0.1 mgKRAS12C-B-C-301
G12D KRAS (1-166), Biotinylated at the C-terminus0.1 mgKRAS12D-B-C-301
G12V KRAS(1-166), Biotinylated at the C-terminus0.1 mgKRAS12V-B-C-301
KRAS G12C Protein, Human, Recombinant, AviTag0.1 mgKRAS12C-301
KRAS G12D Protein, Human, Recombinant, AviTag0.1 mgKRAS12D-301
KRAS G12R Protein, Human, Recombinant, AviTag0.1 mgKRAS12R-301
KRAS G12R Protein, Human, Recombinant, Biotinylated0.1 mgKRAS12R-B-301
KRAS G12V Protein, Human, Biotinylated, Without a His-tag0.1 mgKRAS12V-B-302
KRAS G12V Protein, Human, Recombinant, AviTag0.1 mgKRAS12V-301
KRAS G13D Protein, Human, Recombinant, AviTag0.1 mgKRAS13D-301
KRAS Y96D  Protein, Human, Recombinant, AviTag0.1 mgKRAS96D-301
KRAS Y96D Protein, Human, Recombinant, Biotinylated0.1 mgKRAS96D-B-301
MEK1 Protein, Human, Recombinant, Biotinylated0.05 mgMEK1-B-301
MEK2 Protein, Human, Recombinant, Biotinylated0.05 mgMEK2-B-301
Neurofibromin (NF1), Human, Recombinant0.05 mgNF1-301
PI3Kα-RBD Protein, Human, Biotinylated0.05 mgPIK3A-B-301
Raf1 RBD Protein, Human, Recombinant, Biotinylated0.1 mgRAF1-B-301
RalA Protein, Human, Recombinant, Biotinylated0.1 mgRALA-B-301
RalB Protein, Human, Recombinant, Biotinylated0.1 mgRALB-B-301
Rheb Protein, Human, Recombinant, Biotinylated0.1 mgRHEB-B-301
Wild Type KRAS (1-166) Protein, Biotinylated at the C-terminus0.1 mgKRAS-B-C-301
Wild Type KRAS Protein, Human, Biotinylated, Without a His-tag0.1 mgKRAS-B-302
Wild Type KRAS Protein, Human, Recombinant, AviTag0.1 mgKRAS-301-1
Saposin D, Human, Recombinant0.1 mgSAPD-301-1
Saposin C, Human, Recombinant0.1 mgSAPC-302-1
Phage Display SS320 Chemically Competent E. coli Cells10 X 0.1 ml (20 reactions)SS320-201
Phage Display ER2738 Chemically Competent E. coli Cells10 X 0.1 ml (20 reactions)EREC-201
Phage Display TG1 Chemically Competent E. coli Cells10 X 0.1 ml (20 reactions)TG1-201
Phage Display ER2738 Electrocompetent E. coli Cells10 X 0.05 ml (20 reactions)EREC-201
Phage Display TG1 Electrocompetent E. coli Cells10 X 0.05 ml (20 reactions)ETG1-201
Phage Display SS320 Electrocompetent E. coli Cells10 X 0.05 ml (20 reactions)SS320EC-201



" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Amid Biosciences品牌全系列产品">
艾美捷科技代理Amid Biosciences品牌全系列产品
...
阅读详情
logo 1比1.png

<

艾美捷科技代理Carbon Solutions品牌全系列产品


Carbon Solutions,Inc.(CSI)是一个在碳纳米管技术领域具有显著影响力的品牌,CSI成立于1998年,位于加利福尼亚州里弗赛德。公司自成立之初就明确了其核心目标,即批量生产单壁碳纳米管(SWNT)。CSI因其生产的高质量碳纳米管材料而享有盛誉,已成为领先的纳米技术公司之一。公司能够生产几乎适用于任何应用的碳纳米管,这得益于其对单壁纳米管进行化学处理的能力,从而引入必要的化学官能团,以与常见的工业过程兼容。此外,CSI还是纯度评估技术开发领域的领导者,并制定了碳纳米管工业销售的质量控制和质量保证标准。


CarbonSolutions页面.png


Carbon Solutions产品列表


品名Carbonaceous_PurityMETAL CONTENT规格描述
AP-SWNT60 - 70%< 30 wt% from TGA in air1 gramAs prepared single-wall carbon nanotubes
P2-SWNT> 90%4 - 8 wt. % from TGA in air0.5 gramsPurified, low functionality single-wall carbon nanotubes
P3-SWNT> 90%5 - 7 wt. % from TGA in air0.5 gramsPurified, high functionality single-wall carbon nanotubes
P33-SWNT> 90%4 - 6 wt. % from TGA in air0.1 gramsUltra high purity SWNTs with 1– 3 atomic % carboxylic acid groups, which can be derivatized with a variety of functional groups.
P5-SWNT> 90% (65% ± 15% SWNT loading)4 - 6 wt. % from TGA in air0.1 gramsOrganic soluble, single-wall carbon nanotubes functionalized with ODA
P7-SWNT> 90% (80% ± 10% SWNT loading)4 - 6 wt. % from TGA in air0.1 gramsWater soluble (single-wall carbon nanotubes functionalized with PEG)
P8-SWNT> 90% (35% ± 10% SWNT loading)1 - 3 wt. % from TGA in air0.1 gramsWater soluble (functionalized with PABS)
P9-SWNT> 90%5 - 8 wt. % from TGA in air0.1 gramsAmide functionalized SWNTs
i-SWNT> 45%< 30 wt. % from TGA in air1 gramIndustrial grade electric arc SWNTs synthesized using Ni/Y catalyst
ip-SWNT> 90%> 5 wt. % from TGA in air1 gramIndustrial grade SWNTs purified by air oxidation and subsequently treated to remove the catalyst.  Low functionality and low chemical doping
ipcx-SWNT> 90%> 5 wt. % from TGA in air1 gramIndustrial grade purified SWNTs with carboxylic acid groups
GON/AN/A0.5 gramsGraphene oxide
rGON/AN/A0.5 gramsSynthesized by reduction of GO using sodium borohydride.
NrGO-< 1 wt. % from TGA in air0.5 gramsNitrogen-doped reduced graphene oxide
" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Carbon Solutions品牌全系列产品">
艾美捷科技代理Carbon Solutions品牌全系列产品
...
阅读详情

Copyright © 2026 Powered by Biomatik中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap